| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $2.32 | - | - |
| Q1'26 | $2.27 | $2.42 | +6.6% |
| Q4'25 | $2.37 | $2.58 | +9.1% |
| Q3'25 | $2.32 | $2.37 | +2.2% |
| Q2'25 | $2.16 | $2.02 | -6.7% |
| Q1'25 | $2.01 | $1.96 | -2.5% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $19.6B | - | - |
| Q1'26 | $19.4B | $19.7B | +1.3% |
| Q4'25 | $28.0B | $24.2B | -13.6% |
| Q3'25 | - | $17.9B | - |
| Q2'25 | - | $17.9B | - |
| Q1'25 | - | $18.8B | - |
Market Data
MET is currently trading at $93.58, giving MetLife, Inc. a market cap of 60.22B and a P/E ratio of 16.6. Today's range spans $93.12–$93.73, with shares opening at $93.21 and moving down $0.12 (0.1%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 70/100.
Over the past year MET has traded between $67.33 and $93.81 - the current price is +39.0% off the 52-week low and -0.2% from the high. 25 analysts cover the stock with a Buy consensus and a mean 12-month target of $96.00 (range $75.00–$105.00), implying upside of +2.6%.
The bullish case for MET is built on complementary signals: 95/100 technical score, BUY designation, and bullish sentiment at 70/100. At $93.58 (near 52-week highs within $67.33–$93.81), the stock is at a capitalization - 60.22B - where active managers can build meaningful positions without moving the market. (P/E: 16.6) That combination of signal quality and position-buildability makes this one of the more actionable large-cap setups in Financial Services.
Earnings revision cycles in large-cap Financial Services names tend to compound: when technicals confirm a BUY thesis (95/100) and news sentiment (70/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $93.58 (near 52-week highs), MET's position within the $67.33–$93.81 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).